Cash flow Becton, Dickinson and Company

Stocks

BDX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - NYSE Other stock markets 21:00:03 17/07/2026 BST			5-day change	1st Jan Change
158.17 ^USD	-1.10%		+4.10%	-18.50%

07-14	Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating	MT
07-14	Bactiguard lifted revenue but the operating loss widened	FW

b09cd650fc9c44e32.0MHTqP1ZbXq7XMglV8IXkkPIHGOcr8FgJBm2FPRp_1Q.k7a7z5sNIi70EZlSI7hboBT5djP04rURZUnjbaAcpy3hhOvjvBwCH-wRkQ

Published financial data: BECTON, DICKINSON AND COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	20.25B	18.87B	19.37B	20.18B	21.84B
Total Revenues	20.25B	18.87B	19.37B	20.18B	21.84B
Cost of Goods Sold, Total	10.67B	10.26B	10.55B	11.05B	11.58B
Gross Profit	9.58B	8.61B	8.82B	9.12B	10.26B
Selling General & Admin Expenses, Total	4.87B	4.73B	4.82B	4.92B	5.36B
R&D Expenses	1.34B	1.26B	1.24B	1.19B	1.24B
Other Operating Expenses	-	-4M	18M	173M	2M
Other Operating Expenses, Total	6.21B	5.98B	6.07B	6.28B	6.6B
Operating Income	3.37B	2.64B	2.75B	2.84B	3.66B
Interest Expense, Total	-469M	-398M	-452M	-528M	-613M
Interest And Investment Income	9M	16M	49M	163M	38M
Net Interest Expenses	-460M	-382M	-403M	-365M	-575M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-13M	-28M	-36M	-47M	-47M
Other Non Operating Income (Expenses)	39M	-47M	32M	53M	28M
EBT, Excl. Unusual Items	2.94B	2.18B	2.34B	2.48B	3.07B
Restructuring Charges	-35M	-192M	-313M	-458M	-408M
Merger & Related Restructuring Charges	-185M	-	-	-	-336M
Gain (Loss) On Sale Of Investments	57M	-35M	-3M	5M	-5M
Gain (Loss) On Sale Of Assets	158M	-	268M	-	-
Asset Writedown	-93M	-65M	-	-	-30M
Insurance Settlements	-	-	-	-	-
Legal Settlements	-361M	-21M	-26M	-36M	-297M
Other Unusual Items	-234M	-83M	-608M	13M	-111M
EBT, Incl. Unusual Items	2.24B	1.78B	1.66B	2B	1.88B
Income Tax Expense	150M	148M	132M	300M	203M
Earnings From Continuing Operations	2.09B	1.64B	1.53B	1.7B	1.68B
Earnings Of Discontinued Operations	-	144M	-46M	-	-
Net Income to Company	2.09B	1.78B	1.48B	1.7B	1.68B
Net Income - (IS)	2.09B	1.78B	1.48B	1.7B	1.68B
Preferred Dividend and Other Adjustments	90M	90M	60M	-	-
Net Income to Common Incl Extra Items	2B	1.69B	1.42B	1.7B	1.68B
Net Income to Common Excl. Extra Items	2B	1.54B	1.47B	1.7B	1.68B
Per Share Items
Net EPS - Basic	6.92	5.93	4.97	5.88	5.83
Basic EPS - Continuing Operations	6.92	5.42	5.13	5.88	5.83
Basic Weighted Average Shares Outstanding	289M	285M	286M	290M	288M
Net EPS - Diluted	6.85	5.88	4.94	5.86	5.82
Diluted EPS - Continuing Operations	6.85	5.38	5.1	5.86	5.82
Diluted Weighted Average Shares Outstanding	292M	287M	288M	291M	289M
Normalized Basic EPS	6.34	4.78	5.12	5.35	6.67
Normalized Diluted EPS	6.28	4.74	5.08	5.33	6.65
Dividend Per Share	3.32	3.48	3.64	3.8	4.16
Payout Ratio	50.1	60.82	75.07	64.52	71.28
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	5.64B	4.86B	5.04B	5.13B	6.12B
EBITA	4.77B	4.07B	4.22B	4.31B	5.25B
EBIT	3.37B	2.64B	2.75B	2.84B	3.66B
EBITDAR	5.77B	5B	5.18B	5.32B	6.32B
Effective Tax Rate - (Ratio)	6.69	8.3	7.94	14.96	10.79
Current Domestic Taxes	148M	49M	451M	149M	207M
Current Foreign Taxes	290M	228M	303M	362M	471M
Total Current Taxes	438M	277M	754M	511M	678M
Deferred Domestic Taxes	-286M	-96M	-644M	-169M	-343M
Deferred Foreign Taxes	-2M	-33M	22M	-42M	-131M
Total Deferred Taxes	-288M	-129M	-622M	-211M	-474M
Normalized Net Income	1.83B	1.36B	1.46B	1.55B	1.92B
Interest Capitalized	44M	46M	51M	57M	62M
Non-Cash Pension Expense	-13M	9M	83M	43M	34M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	1.34B	1.26B	1.24B	1.19B	1.26B
Net Rental Expense, Total	132M	138M	145M	190M	196M
Imputed Operating Lease Interest Expense	29.72M	28.29M	35.39M	47.64M	51.7M
Imputed Operating Lease Depreciation	102M	110M	110M	142M	144M
Stock-Based Comp., COGS (Total)	43M	46M	50M	51M	53M
Stock-Based Comp., R&D Exp. (Total)	36M	37M	41M	42M	44M
Stock-Based Comp., SG&A Exp. (Total)	158M	156M	170M	156M	160M
Stock-Based Comp., Other (Total)	1M	1M	-	-	5M
Total Stock-Based Compensation	238M	240M	261M	249M	262M

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.28B	1.01B	1.42B	1.72B	641M
Short Term Investments	12M	8M	8M	445M	8M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	2.3B	1.01B	1.42B	2.16B	649M
Accounts Receivable, Total	2.5B	2.19B	2.53B	3.03B	2.99B
Total Receivables	2.5B	2.19B	2.53B	3.03B	2.99B
Inventory	2.87B	3.22B	3.27B	3.84B	3.89B
Prepaid Expenses	1.07B	1.56B	1.38B	1.29B	1.51B
Restricted Cash	109M	153M	65M	139M	210M
Other Current Assets, Total	-1M	-	-	-1M	-
Total Current Assets	8.84B	8.14B	8.68B	10.47B	9.26B
Gross Property Plant And Equipment	13.39B	12.9B	14.1B	15.25B	16B
Accumulated Depreciation	-6.55B	-6.4B	-7.02B	-7.56B	-8.12B
Net Property Plant And Equipment	6.84B	6.49B	7.07B	7.7B	7.88B
Goodwill	23.9B	24.62B	24.52B	26.46B	26.61B
Other Intangibles, Total	12.78B	12.31B	10.95B	10.92B	9.4B
Accounts Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	1.34B	1.18B	1.64B	1.5B	1.74B
Other Long-Term Assets, Total	162M	190M	-82M	241M	431M
Total Assets	53.87B	52.93B	52.78B	57.29B	55.32B
Liabilities
Accounts Payable, Total	1.79B	1.7B	1.64B	1.9B	1.97B
Accrued Expenses, Total	4.03B	3.66B	3.19B	4.1B	3.83B
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	500M	2.18B	1.14B	2.17B	1.56B
Current Portion of Leases	126M	118M	117M	142M	135M
Current Income Taxes Payable	176M	157M	139M	168M	329M
Unearned Revenue Current, Total	-	-	412M	482M	481M
Other Current Liabilities	-	-	1M	-	1M
Total Current Liabilities	6.63B	7.81B	6.64B	8.96B	8.31B
Long-Term Debt	17.11B	13.89B	14.74B	17.94B	17.62B
Long-Term Leases	344M	384M	414M	667M	704M
Pension & Other Post Retirement Benefits	1.23B	902M	1.02B	942M	1.07B
Deferred Tax Liability Non Current	4.76B	2.44B	2.14B	2.07B	1.77B
Other Non Current Liabilities	119M	2.22B	2.03B	824M	457M
Total Liabilities	30.19B	27.65B	26.98B	31.4B	29.94B
Preferred Stock Convertible	2M	2M	-	-	-
Total Preferred Equity	2M	2M	-	-	-
Common Stock, Total	365M	365M	371M	371M	371M
Additional Paid In Capital	19.27B	19.55B	19.72B	19.89B	20.08B
Retained Earnings	13.83B	15.16B	15.54B	16.14B	16.62B
Treasury Stock	-7.72B	-8.33B	-8.3B	-8.81B	-9.81B
Comprehensive Income and Other	-2.06B	-1.46B	-1.52B	-1.71B	-1.87B
Total Common Equity	23.68B	25.28B	25.8B	25.89B	25.39B
Total Equity	23.68B	25.28B	25.8B	25.89B	25.39B
Total Liabilities And Equity	53.87B	52.93B	52.78B	57.29B	55.32B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	284M	283M	290M	289M	285M
ECS Total Common Shares Outstanding	284M	283M	290M	289M	285M
Book Value / Share	83.22	89.22	88.83	89.55	88.96
Tangible Book Value	-13.01B	-11.65B	-9.67B	-11.49B	-10.63B
Tangible Book Value Per Share	-45.73	-41.12	-33.31	-39.75	-37.24
Total Debt	18.08B	16.57B	16.41B	20.92B	20.02B
Net Debt	15.78B	15.55B	14.99B	18.76B	19.37B
Debt Equivalent of Unfunded Proj. Benefit Obligation	667M	392M	488M	356M	371M
Debt Equivalent Oper. Leases	1.06B	1.1B	1.16B	1.52B	1.57B
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	641M	707M	714M	803M	860M
Inventories - Work In Process, Total	402M	397M	381M	443M	490M
Inventories - Finished Goods, Total	1.82B	2.12B	2.18B	2.6B	2.54B
Land - (BS)	137M	127M	131M	129M	128M
Buildings, Total	3.26B	3.25B	3.54B	3.73B	3.9B
Machinery, Total	9.3B	8.77B	9.61B	10.2B	10.76B
Full Time Employees	75K	77K	73K	74K	72K
Accumulated Allowance for Doubtful Accounts (Supple)	76M	65M	65M	64M	82M

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	2.09B	1.78B	1.48B	1.7B	1.68B
Depreciation & Amortization - CF	870M	799M	823M	818M	876M
Amortization of Goodwill and Intangible Assets - (CF)	1.4B	1.43B	1.46B	1.47B	1.59B
Depreciation & Amortization, Total	2.27B	2.23B	2.29B	2.29B	2.46B
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-268M	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	237M	233M	259M	247M	258M
Tax Benefit from Stock Options	15M	32M	19M	-	-
Net Cash From Discontinued Operations	-	298M	-1M	-46M	-
Other Operating Activities, Total	-272M	-294M	-162M	-687M	-168M
Change In Accounts Receivable	-95M	32M	-290M	-453M	71M
Change In Inventories	-104M	-631M	-15M	98M	-410M
Change In Accounts Payable	687M	-473M	-517M	625M	-185M
Change in Other Net Operating Assets	-186M	-436M	192M	23M	-276M
Cash from Operations	4.65B	2.77B	2.99B	3.8B	3.43B
Capital Expenditure	-1.23B	-973M	-874M	-725M	-760M
Cash Acquisitions	-508M	-2.07B	-	-3.92B	-
Divestitures	-	-	540M	-	-
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-421M	422M
Other Investing Activities, Total	-141M	-177M	-382M	-444M	-480M
Cash from Investing	-1.88B	-3.22B	-716M	-5.51B	-818M
Short Term Debt Issued, Total	-	230M	-	400M	455M
Long-Term Debt Issued, Total	4.87B	497M	1.66B	4.52B	-
Total Debt Issued	4.87B	727M	1.66B	4.92B	455M
Short Term Debt Repaid, Total	-	-	-230M	-	-
Long-Term Debt Repaid, Total	-5.11B	-805M	-2.16B	-1.14B	-1.79B
Total Debt Repaid	-5.11B	-805M	-2.38B	-1.14B	-1.79B
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-1.75B	-500M	-	-500M	-1B
Common Dividends Paid	-958M	-992M	-	-1.1B	-1.2B
Preferred Dividends Paid	-90M	-90M	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-1.11B	-	-
Common & Preferred Stock Dividends Paid	-1.05B	-1.08B	-1.11B	-1.1B	-1.2B
Other Financing Activities, Total	-265M	924M	-119M	-88M	-87M
Cash from Financing	-3.31B	-736M	-1.96B	2.09B	-3.62B
Foreign Exchange Rate Adjustments	15M	-45M	5M	4M	-
Miscellaneous Cash Flow Adjustments	-1M	-1M	-	-	-
Net Change in Cash	-525M	-1.23B	322M	375M	-1B
Supplemental Items
Cash Interest Paid	474M	390M	452M	473M	628M
Cash Income Tax Paid (Refund)	670M	532M	629M	653M	599M
Levered Free Cash Flow	3.65B	1.82B	2.86B	3.46B	3.54B
Unlevered Free Cash Flow	3.94B	2.07B	3.14B	3.79B	3.93B
Change In Net Working Capital	-558M	1.07B	256M	-207M	326M
Net Debt Issued / Repaid	-243M	-78M	-723M	3.78B	-1.33B

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	3.9	3.09	3.25	3.23	4.06
Return on Total Capital	5.02	3.94	4.09	3.99	4.96
Return On Equity %	8.82	6.68	5.99	6.6	6.54
Return on Common Equity	8.44	6.31	5.76	6.6	6.54
Margin Analysis
Gross Profit Margin %	47.29	45.65	45.55	45.22	46.98
SG&A Margin	24.04	25.04	24.87	24.39	24.55
EBITDA Margin %	27.86	25.78	26.01	25.4	28.04
EBITA Margin %	23.57	21.55	21.76	21.35	24.03
EBIT Margin %	16.64	13.97	14.2	14.07	16.77
Income From Continuing Operations Margin %	10.33	8.66	7.9	8.45	7.68
Net Income Margin %	10.33	9.43	7.66	8.45	7.68
Net Avail. For Common Margin %	9.89	8.19	7.59	8.45	7.68
Normalized Net Income Margin	9.06	7.22	7.56	7.68	8.78
Levered Free Cash Flow Margin	18.03	9.67	14.74	17.16	16.23
Unlevered Free Cash Flow Margin	19.48	10.99	16.2	18.79	17.98
Asset Turnover
Asset Turnover	0.38	0.35	0.37	0.37	0.39
Fixed Assets Turnover	3.07	2.92	2.86	2.73	2.8
Receivables Turnover (Average Receivables)	8.27	8.31	8.2	7.25	7.25
Inventory Turnover (Average Inventory)	3.81	3.44	3.25	3.11	2.99
Short Term Liquidity
Current Ratio	1.33	1.04	1.31	1.17	1.11
Quick Ratio	0.72	0.41	0.6	0.58	0.44
Operating Cash Flow to Current Liabilities	0.7	0.35	0.45	0.42	0.41
Days Sales Outstanding (Average Receivables)	44.12	43.92	44.51	50.49	50.36
Days Outstanding Inventory (Average Inventory)	95.92	106.18	112.4	117.82	121.95
Average Days Payable Outstanding	53.22	58.44	57.52	55.69	60.73
Cash Conversion Cycle (Average Days)	86.82	91.66	99.4	112.62	111.58
Long Term Solvency
Total Debt/Equity	76.36	65.53	63.61	80.8	78.85
Total Debt / Total Capital	43.3	39.59	38.88	44.69	44.09
LT Debt/Equity	73.72	56.44	58.74	71.87	72.17
Long-Term Debt / Total Capital	41.8	34.1	35.9	39.75	40.35
Total Liabilities / Total Assets	56.04	52.24	51.13	54.81	54.11
EBIT / Interest Expense	7.18	6.62	6.09	5.38	5.97
EBITDA / Interest Expense	12.31	12.57	11.47	10.07	10.31
(EBITDA - Capex) / Interest Expense	9.69	10.13	9.54	8.7	9.07
Total Debt / EBITDA	3.13	3.31	3.17	3.94	3.17
Net Debt / EBITDA	2.73	3.11	2.89	3.53	3.07
Total Debt / (EBITDA - Capex)	3.98	4.11	3.81	4.56	3.6
Net Debt / (EBITDA - Capex)	3.47	3.86	3.48	4.09	3.48
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	18.29	-1.36	2.66	4.16	8.24
Gross Profit, 1 Yr. Growth %	20.92	-2.34	2.43	11.69	12.45
EBITDA, 1 Yr. Growth %	20.71	-3.68	3.58	16.87	19.31
EBITA, 1 Yr. Growth %	22.23	-3.72	3.69	20.91	21.62
EBIT, 1 Yr. Growth %	33.69	-6.56	4.36	35.37	28.63
Earnings From Cont. Operations, 1 Yr. Growth %	139.36	1.93	-6.42	11.44	-1.58
Net Income, 1 Yr. Growth %	139.36	-14.96	-16.58	14.89	-1.58
Normalized Net Income, 1 Yr. Growth %	46.09	-8.6	7.57	46.72	23.31
Diluted EPS Before Extra, 1 Yr. Growth %	152.77	3.86	-5.2	14.9	-0.68
Accounts Receivable, 1 Yr. Growth %	4.13	-6.77	15.65	19.69	-1.29
Inventory, 1 Yr. Growth %	4.48	17.54	1.52	17.42	1.33
Net Property, Plant and Equip., 1 Yr. Growth %	7.85	0.7	8.93	8.81	2.4
Total Assets, 1 Yr. Growth %	-0.27	-1.73	-0.29	8.54	-3.42
Tangible Book Value, 1 Yr. Growth %	-4.84	-10.27	-16.97	18.79	-7.53
Common Equity, 1 Yr. Growth %	-0.37	6.78	2.04	0.36	-1.93
Cash From Operations, 1 Yr. Growth %	31.31	-39.94	13.48	27.07	-9.69
Capital Expenditures, 1 Yr. Growth %	51.98	-18.51	-10.17	-17.05	4.83
Levered Free Cash Flow, 1 Yr. Growth %	4.75	-44.74	56.51	41.44	2.23
Unlevered Free Cash Flow, 1 Yr. Growth %	3.37	-42.32	51.36	38.89	3.43
Dividend Per Share, 1 Yr. Growth %	5.06	4.82	4.6	4.4	9.47
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	8.22	8.35	0.63	3.41	6.18
Gross Profit, 2 Yr. CAGR %	7.49	9.99	0.02	3.36	12.07
EBITDA, 2 Yr. CAGR %	4.19	9.83	-0.12	3.42	17.73
EBITA, 2 Yr. CAGR %	3.66	10.97	-0.08	3.86	20.82
EBIT, 2 Yr. CAGR %	6.97	17.23	-1.25	5.24	31.12
Earnings From Cont. Operations, 2 Yr. CAGR %	30.26	115.52	-2.33	2.12	4.72
Net Income, 2 Yr. CAGR %	30.26	42.67	-15.78	-2.1	6.34
Normalized Net Income, 2 Yr. CAGR %	11.33	24.4	-0.84	8.51	33.44
Diluted EPS Before Extra, 2 Yr. CAGR %	31.86	148.67	-0.78	4.37	6.83
Accounts Receivable, 2 Yr. CAGR %	3.19	-4.41	3.84	17.66	8.7
Inventory, 2 Yr. CAGR %	5.42	8.41	9.23	9.18	9.07
Net Property, Plant and Equip., 2 Yr. CAGR %	9.93	1.2	4.73	8.87	5.56
Total Assets, 2 Yr. CAGR %	2.01	-1	-1.01	4.03	2.38
Tangible Book Value, 2 Yr. CAGR %	-13.22	-7.68	-13.68	-0.68	4.81
Common Equity, 2 Yr. CAGR %	5.98	3.14	4.38	1.2	-0.79
Cash From Operations, 2 Yr. CAGR %	18.13	-11.02	-19.8	20.08	7.12
Capital Expenditures, 2 Yr. CAGR %	13.42	12.48	-14.44	-13.68	-6.75
Levered Free Cash Flow, 2 Yr. CAGR %	12.42	-23.4	-7	39.47	19.83
Unlevered Free Cash Flow, 2 Yr. CAGR %	9.52	-22.36	-6.57	36.72	19.49
Dividend Per Share, 2 Yr. CAGR %	3.82	4.94	4.71	4.5	6.9
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.2	2.96	6.42	1.79	4.99
Gross Profit, 3 Yr. CAGR %	7.05	1.29	7.41	1.14	6.3
EBITDA, 3 Yr. CAGR %	5.9	-2.18	7.71	0.49	8.51
EBITA, 3 Yr. CAGR %	5.82	-2.9	8.49	0.67	9.53
EBIT, 3 Yr. CAGR %	6.72	-3.62	12.78	0.22	12.62
Earnings From Cont. Operations, 3 Yr. CAGR %	88.77	9.86	63.2	2.06	0.87
Net Income, 3 Yr. CAGR %	88.77	13	19.3	-6.59	-1.93
Normalized Net Income, 3 Yr. CAGR %	10.86	-2.73	18.52	1.34	13.34
Diluted EPS Before Extra, 3 Yr. CAGR %	125.17	10.94	80.31	4.2	2.66
Accounts Receivable, 3 Yr. CAGR %	2.5	-2.24	1.86	8.88	10.97
Inventory, 3 Yr. CAGR %	5.35	7.72	6.07	11.9	6.5
Net Property, Plant and Equip., 3 Yr. CAGR %	8.36	4.69	3.71	6.07	6.67
Total Assets, 3 Yr. CAGR %	-0.02	0.75	-0.77	2.07	1.48
Tangible Book Value, 3 Yr. CAGR %	-11.94	-12.3	-10.89	-3.99	-3.02
Common Equity, 3 Yr. CAGR %	4.09	6.25	2.77	3.03	0.14
Cash From Operations, 3 Yr. CAGR %	17.49	-5.96	-5.1	-6.5	9.2
Capital Expenditures, 3 Yr. CAGR %	11.21	0.55	4.36	-15.32	-7.91
Levered Free Cash Flow, 3 Yr. CAGR %	15.63	-14.2	-2.8	1.59	25.8
Unlevered Free Cash Flow, 3 Yr. CAGR %	12.06	-14.25	-3.01	1.79	24.63
Dividend Per Share, 3 Yr. CAGR %	3.44	4.15	4.83	4.6	6.13
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.16	9.31	3.92	3.14	6.32
Gross Profit, 5 Yr. CAGR %	9.83	7.63	2.48	1.94	7.58
EBITDA, 5 Yr. CAGR %	11.51	7.87	1.19	-0.27	8.71
EBITA, 5 Yr. CAGR %	11.98	7.78	0.92	-0.61	9.71
EBIT, 5 Yr. CAGR %	9.32	3.28	-0.15	-0.72	13.81
Earnings From Cont. Operations, 5 Yr. CAGR %	16.47	8.25	37.53	6.7	36.66
Net Income, 5 Yr. CAGR %	16.47	10.09	36.69	6.7	13.93
Normalized Net Income, 5 Yr. CAGR %	10.26	4.05	1.7	0.94	16.86
Diluted EPS Before Extra, 5 Yr. CAGR %	8.82	3.18	53.42	8.26	46.24
Accounts Receivable, 5 Yr. CAGR %	4.99	4.67	1.79	5.28	4.54
Inventory, 5 Yr. CAGR %	10.76	12.14	5.95	8.3	7.26
Net Property, Plant and Equip., 5 Yr. CAGR %	11.88	6.96	5.65	6.34	4.45
Total Assets, 5 Yr. CAGR %	16.05	7	-0.42	2.05	0.48
Tangible Book Value, 5 Yr. CAGR %	16.48	86.96	-12.67	-7.83	-4.91
Common Equity, 5 Yr. CAGR %	25.41	14.32	4.21	4.2	1.33
Cash From Operations, 5 Yr. CAGR %	12.67	1.66	0.85	2.66	-0.39
Capital Expenditures, 5 Yr. CAGR %	12.18	6	-0.47	-5.4	-0.24
Levered Free Cash Flow, 5 Yr. CAGR %	17.98	1.27	3.88	3.69	2.65
Unlevered Free Cash Flow, 5 Yr. CAGR %	16.47	0.34	2.29	2.89	2.68
Dividend Per Share, 5 Yr. CAGR %	4.69	3.57	3.94	4.29	5.65